by Ariana | Nov 27, 2024 | Article
Supporting Lupus Canada During Canada Post Service Disruptions We want to ensure your generous support reaches Lupus Canada without delay, even as the Canada Post strike may cause temporary disruptions in mail service. If you typically send donations by mail, there...
by Ariana | Nov 27, 2024 | Article
CANVAS Network for Vaccine Safety Lupus Canada is pleased to share the Canadian National Vaccine Safety (CANVAS) Network, a valuable resource for individuals across Canada to monitor and report on vaccine safety. The CANVAS Network plays a vital role in tracking the...
by Ariana | Oct 31, 2024 | Article
A pilot study examining the relationship between cognitive dysfunction and cognitive fatigue in SLE using structural and functional MRIs of the brain and focusing on the underlying mechanisms Cognitive impairment is commonly experienced by people with lupus. Treatment...
by Cora Novacut-Lee | Jul 12, 2024 | Article
Exciting Breakthrough in Lupus Research!Scientists at Northwestern Medicine and Brigham and Women’s Hospital have potentially uncovered a root cause of lupus, Dr. Deepak Rao states, “This could explain the vast majority of lupus cases.” This discovery...
by Ariana | Jun 27, 2024 | Article
We are pleased to announce that Belimumab (Benlysta), a prescription drug used to treat adults with lupus-related kidney inflammation (active lupus nephritis), has been included in the Exception Drug Status (EDS) Benefit of the Saskatchewan and Nova Scotia Formularies...
